Russell Investments Group, Ltd. Pacira Bio Sciences, Inc. Transaction History
Russell Investments Group, Ltd.
- $66.8 Billion
- Q3 2024
A detailed history of Russell Investments Group, Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 984 shares of PCRX stock, worth $16,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
984
Previous 55,495
98.23%
Holding current value
$16,108
Previous $1.59 Million
99.12%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding PCRX
# of Institutions
266Shares Held
50.7MCall Options Held
347KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$131 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$86.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$81.2 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$33 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$32.4 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $750M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...